What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire

Melanoma Research

Volumn 23, Issue 2, 2013, Pages 167-174

  Winstanley, Julie B ^a   White, Edward G ^b   Boyle, Frances M ^a   Thompson, John F ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cancer; measurement of quality of life; melanoma; psychosocial; qualitative; quality of life issues; questionnaire

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; AUSTRALIA; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUESTIONNAIRE; FAMILY; FEMALE; HEALTH CARE COST; HUMAN; INTERVIEW; MALE; MEDICAL DECISION MAKING; MELANOMA; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SYSTEMIC THERAPY; WORK;

EID: 84874949339     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32835e5932     Document Type: Article

References (26)

1. International Agency for Research on Cancer. Countries with the highest incidence of melanoma cancer. Available at: http://www.aneki.com/melanoma- cancer-countries.html [Accessed 1 July 2012].
2. Cancer Council NSW. Understanding melanoma: a guide for people with cancer, their families and friends. ISBN 186507 0467. Sydney, Australia: Cancer Council NSW; 2005.
3. De Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, Coebergh JW. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the South East of the Netherlands. Ann Oncol 2007; 18:1110-1116.
4. De Vries E, Dore JF, Autier P, Eggermont AM, Coebergh JW. Patients' perception of the cause of their melanoma differs from that of epidemiologists. Br J Dermatol 2002; 147: 388-389.
5. The WHOQOL Group. The World Health Organization quality of life assessment: position paper from the World Health Organization. Soc Sci Med 1995; 41:1403.
6. Pollack A. New drug to help body fight melanoma. Sydney Morning Herald. Media article, 28 March 2011.
7. Long G, Menzies A, Nagrial A, Haydu L, Hamilton A, Mann G, et al. Prognostic and clinicopathologic associations of oncogenic BRAF in mestastatic melanoma. J Clin Oncol 2011; 29: 1239-1246.
8. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J. BRIM-3 study group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507-2516.
9. Boyle D. Psychological adjustment to the melanoma experience. Semin Oncol Nurs 2003; 19:70-77.
10. Brown J, King M, Butow P, Dunn S, Coates A. Patterns over time in quality of life, coping and psychosocial adjustment in late stage melanoma patients: an application of multilevel models. Qual Life Res 2000; 9:75-85.
11. Mols F, Holterhues C, Nijsten T, van de Poll-Franse L. Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer 2010; 46:573-580.
12. Bottomley A, Coens C, Suciu S, Santinami M, Kruit W, Testori A, et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol 2009; 27:2916-2923.
13. Cornish D, Holterhues C, Van de Poll-Franse L, Coeburgh J, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6):51-58.
14. Cormier J, Davidson L, Xing Y,Webster K, Cella D. Measuring quality of life in patients with melanoma: development of the fact-melanoma subscale. J Support Oncol 2005; 3:139-145.
15. Cormier J, Ross M, Gershenwald J, Lee J, Mansfield P, Camacho L, et al. Prospective assessment of the reliability, validity and sensitivity to change of the functional assessment of cancer therapy-melanoma questionnaire. Cancer 2008; 112:2249-2257.
16. Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M. The impact of generalised malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993; 2:193-203.
17. Sigurdardottir V, Brandberg Y, Sullivan M. Criterion-based validation of the EORTC QLQ-C36 in advanced melanoma: the CIPS questionnaire and proxy raters. Qual Life Res 1996; 5:375-386.
18. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570-579.
19. Swartz R, Baum G, Askew R, Pialmer J, Ross M, Cormier J. Reducing patient burden to the FACT-Melanoma quality of life questionnaire. Melanoma Res 2012; 22:158-163.
20. Winstanley J, Boyle F, Saw R, Thompson J. The FACT-melanoma quality-oflife instrument: comparison of a five and four point response scale using the Rasch measurement model. Melanoma Res 2012 (in press).
21. Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365-376.
22. Rumpold G, Augustin M, Zschocke I, Strittmatter G, Sollner W. The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma. Psychother Psychosom Med Psychol 2001; 51:25-33.
23. Foddy W. Construction questions for interviews and questionnaires: theory and practice in social research. Cambridge: Cambridge University Press; 1993.
24. Holsti O. Content analysis for the social sciences and humanities. Massachusetts: Addison-Wesley; 1969.
25. PoCoG. What do we mean by quality of life. Resource document. Available at: http://www.pocog.org.au/content.aspx?page =qoloverview [Accessed 30 January 2012].
26. Johnson C, Aaronson N, Blazeby J, Bottomley A, Fayers P, Koller M, et al. The EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules. 4th ed. Brussels: EORTC Brussels; 2011.